Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
#DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials!
Contact Hexoskin to learn more.
This week, Canadian Space Agency Astronaut David Saint-Jacques deployed and tested for the first time in space a new Canadian technology: the Bio-Monitor System.
This advanced smart shirt is designed to measure and record vital signs in microgravity environment. It will help keep an eye on astronauts' health and enable medical research in space by continuously measuring physiological data.
The Canadian Space Agency's Bio-Monitor is designed to easily send information to the ground, where scientists can monitor astronauts' physiology around the clock as they orbit the planet. Once operational it will be available for the next five years to all participating countries to the International Space Station.
To learn more: http://asc-csa.gc.ca/eng/missions/expedition58/default.asp.
Commuting by bike is a great way to include physical activity in our day-to-day living. However the impact of air pollution on cyclists is not something that is well understood.
Columbia University researchers Steven Chillrud, Darby Jack, and their colleagues from the Lamont-Doherty Earth Observatory have been using Hexoskin smart shirts and other sensors to collect data on pollution exposure in a real-world settings. This allows them to map pollution exposure around New York city. These maps can be used by cyclists and policy makers to better plan bike paths and bike lanes.
This project will have an important impact on urban design and mobility. Vice News covered their research project this week in this video:
The Hexoskin Connected Health Platform is used by researchers in many domains all around the world. Remote & Continuous Respiratory Monitoring is a field of interest that is gaining momentum, but few non-invasive solutions exist to monitor the lung function of subjects and patients.
We invite you to our second webinar that will cover our latest results and applications in respiratory research. We will also present how Hexoskin can monitor COPD patients by using its very unique physiological data.
Webinar: Remote & Continuous Respiratory Monitoring with Hexoskin
30 May 2018, at 12:00 PM (EST) - via the Zoom Video Conferencing software
Speaker: Thu Ngan Trinh, PhD, Clinical Application Specialist at Hexoskin
Guest Speaker: Ruud van Leuteren, MSc, PhD Candidate in Neonatology at the Academic Medical Centre in Amsterdam.
If you are unable to attend, we still invite you to register and we will send you the recorded webinar by email afterward.
We look forward to your presence at this new webinar!
Founded in 2006, Hexoskin has designed a system to minimize user setup time and to maximize vital signs monitoring over long periods in a non-obstructive way with sensors embedded in a Smart Shirt. Data are synced to local and remote servers for health data management and analysis. Hexoskin offers a non-invasive solution for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress and mental illness.
Hexoskin will be attending the BIO International Convention in Boston, June 4-7, 2018 for its second year! The Smart Clothing industry's leader will present its new clinically validated collection of Smart Garments for clinical research. Hexoskin will also showcase the Hexoskin Smart, the best health monitor for continuous cardiac, respiratory, activity and sleep tracking. Hexoskin will also unveil a new solution to manage clinical trials and report real-world evidence with Machine Learning & AI. Come meet us!View full article →
Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.
"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.” That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."
Read more on Fierce Pharma.
Erica Wiebe won gold in 75kg Freestyle wrestling in Rio de Janeiro at the 2016 Summer Olympics, and she donates her Hexoskin to the Canada Museum of Sciences and Technology (Ottawa). We are proud to have been part of her physical preparation!
Picture by: Ashley Fraser (Post Media)
She also said in an interview that she will wear her Hexoskin in the next Olympic Games: ''and as I prepare for Tokyo 2020 I'm going to be using it too.''
Everyday, first responders put their own lives at risk to help individuals, families, and communities. They experience frontline tragical issues, such as accidents, deaths, murders, etc. In Canada, according to the Tema Conter Memorial Trust, ‘’PTSD, Post Traumatic Stress Disorder, is a very real phenomenon facing over 20% of all First Responders’’ (CASP, 2016).
Health data are useful to get insights about the individual’s vitals. Hexoskin provides the physiological data, which gives an easy access to the vital signs information in order to determine the appropriate prevention solutions. Hexoskin can measure and report in real-time, high-level actionable data such as readiness information; remote dashboard for command center; focus and cognitive assessment; stress and fatigue monitoring; mood status monitoring; energy expenditure and metabolism monitoring.View full article →
Hexoskin is attending the 2017 BIO conference in San Diego this week, and will be demonstrating its connected health platform and biometric shirt at the Quebec pavilion (booth 4315).
The Hexoskin open-data platform enables the development of new digital markers, third-party device integration, ePROs, artificial intelligence and application-specific development.
In order to meet clinical trial development requirements, Hexoskin works in partnership with pharma and biotechs to design efficient protocols for continuous patient monitoring. Clinical areas of interest include those with a need for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress, mental illness, etc.
The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to pharma and biotech companies.
The Department of Homeland Security and Grant County Sheriff’s Office recently tested new technologies for first responders in diverse emergency scenarios in the Gorge Amphitheater in Washington state. Some first responders participating in the program are using Hexoskin to monitor their vitals and their data are transmitted to the command center using smartphones. Read the article ''First Responders test new communications tech in partnership with Homeland Security'' for more information.